C4 Therapeutics Inc
(CCCC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,476 | 29,754 | 49,551 | 57,296 | 46,004 |
| Marketable Securities | 220,849 | 246,399 | 264,102 | 250,484 | 245,170 |
| Receivables | 528 | 1,473 | 1,488 | 1,709 | 1,773 |
| TOTAL | $278,452 | $287,557 | $325,456 | $318,365 | $302,946 |
| Non-Current Assets | |||||
| PPE Net | 7,640 | 7,400 | 7,415 | 6,337 | 3,026 |
| Investments And Advances | 34,706 | 60,962 | 52,358 | 90,057 | 130,478 |
| Other Non-Current Assets | 75,238 | 74,921 | 76,210 | 77,716 | 79,035 |
| TOTAL | $117,584 | $143,283 | $135,983 | $174,110 | $212,539 |
| Total Assets | $396,036 | $430,840 | $461,439 | $492,475 | $515,485 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,287 | 2,287 | 2,250 | 750 | 750 |
| Accounts payable and accrued liabilities | 1,034 | 1,172 | 2,370 | 4,446 | 3,405 |
| Accrued Expenses | 16,295 | 19,769 | 17,941 | 16,958 | 9,840 |
| TOTAL | $39,380 | $44,546 | $45,267 | $46,148 | $46,988 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,621 | 9,195 | 9,052 | 10,372 | 10,194 |
| Deferred Revenues | 14,937 | 16,618 | 18,129 | 22,170 | 31,266 |
| Other Non-Current Liabilities | 69,720 | 70,970 | 72,176 | 73,371 | 74,754 |
| TOTAL | $94,186 | $97,060 | $97,993 | $101,734 | $103,968 |
| Total Liabilities | $133,566 | $141,606 | $143,260 | $147,882 | $150,956 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,064 | 49,051 | 48,957 | 48,914 | 48,797 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -430,670 | -395,890 | -358,705 | -326,747 | -299,335 |
| Other shareholders' equity | -2,470 | -4,137 | -5,409 | -4,581 | -3,650 |
| TOTAL | $262,470 | $289,234 | $318,179 | $344,593 | $364,529 |
| Total Liabilities And Equity | $396,036 | $430,840 | $461,439 | $492,475 | $515,485 |